Drug-induced arthritis.
D000208:Acute Disease; D000925:Anticoagulants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D001167:Arteritis / Q000139:chemically induced; D001168:Arthritis / Q000139:chemically induced*; D001463:Barbiturates / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004487:Edema / Q000139:chemically induced; D006073:Gout / Q000139:chemically induced; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007049:Iatrogenic Disease / Q000139:chemically induced*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008634:Mersalyl / Q000009:adverse effects; D010018:Osteomalacia / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D010406:Penicillins / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D011718:Pyrazinamide / Q000009:adverse effects; D013390:Succinylcholine; D013449:Sulfonamides / Q000009:adverse effects; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000925:Anticoagulants; D000959:Antihypertensive Agents; D001463:Barbiturates; D003276:Contraceptives, Oral; D004071:Digitalis Glycosides; D010406:Penicillins; D013449:Sulfonamides; D006830:Hydralazine; D011718:Pyrazinamide; D008634:Mersalyl; D013390:Succinylcholine; D011342:Procainamide